ロード中...
Antidepressant-like properties of sarizotan in experimental Parkinsonism
RATIONALE: Depression and anxiety are common symptoms in Parkinson's disease for which there are no optimal treatments. Sarizotan, an agonist at serotonin receptors and partial agonist at dopamine D(2)-like receptors, has shown antidyskinetic effects in Parkinson's disease. Based on its ph...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3222806/ https://ncbi.nlm.nih.gov/pubmed/21647579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-011-2356-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|